Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma
Condition(s):Non Hodgkin LymphomaLast Updated:January 13, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Non Hodgkin LymphomaLast Updated:January 13, 2021Completed
Condition(s):Multiple Myeloma; Leukemia; Lymphoid; Lymphoma; Non-HodgkinLast Updated:July 20, 2016Completed
Condition(s):B-cell Non-Hodgkin’s LymphomaLast Updated:October 25, 2021Not yet recruiting
Condition(s):Solid Tumor; Non Hodgkin LymphomaLast Updated:April 24, 2023Terminated
Condition(s):Non-Hodgkin LymphomaLast Updated:December 7, 2023Not yet recruiting
Condition(s):Non-Hodgkin’s Lymphoma; Mantle Cell LymphomaLast Updated:July 22, 2010Completed
Condition(s):B-Cell Non-Hodgkin’s LymphomaLast Updated:December 15, 2022Recruiting
Condition(s):Non-Hodgkin Lymphoma, B-cellLast Updated:March 22, 2024Not yet recruiting
Condition(s):Non-Hodgkin’s LymphomaLast Updated:November 27, 2020Completed
Condition(s):Non-Hodgkin’s Lymphoma, Burkitt’sLast Updated:December 21, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.